Publication
PEERS ASSISTING TREATMENT OF HEPATITIS C (PATH) - PROJECT AND EVALUATION EXECUTIVE SUMMARY 2021
Publication
PEERS ASSISTING TREATMENT OF HEPATITIS C (PATH) - PROJECT AND EVALUATION REPORT 2021
Publication
This publication outlines national and international activities that will enable reductions in hepatitis C incidence and mortality.
Publication
The authors developed an investment case for hepatitis C for the six WHO world regions, which is the first to consider both indirect and direct economic benefits in this context.
Publication
Hepatitis C elimination programs in Australia should focus on increasing testing rates and linkage with care to maintain adequate levels of treatment.
Publication
A paper publishing in the International Journal of Drug Policy assessing the feasibility and acceptability of HCV point-of-care testing at needle and syringe exchange programs.
Publication
A poster presented at AVHEC 2019 describing patterns of hepatitis C antibody testing in primary care prior to and following the listing of Direct Acting Antivirals on the pharmaceutical benefits scheme.
Publication
A poster presented at AVHEC 2019 on a nurse-led model of care to increase the capacity of primary care clinics to provide hepatitis C testing and treatment to people who inject drugs.
Publication
A poster presented at AVHEC 2019 showing a mapping project that aimed to identify and describe different sub populations of people who inject drugs and their barriers and enablers to hepatitis C treatment.
Publication
A barrier to hepatitis C treatment for people who inject drugs (PWID) is needing to attend multiple appointments for diagnosis. Point-of-care hepatitis C tests provide results within 20 to 105 minutes and can be offered opportunistically in nonclinical settings such as needle syringe programmes. In this nested qualitative study, we explored the acceptability of point-of-care testing for PWID.
Publication
A paper published in Alimentary Pharmacology and Therapeutics that used PBS data to determine the number of DAA prescriptions commenced before and after universal access from March 2016 to June 2017. The authors inferred facilitators and barriers to treatment uptake, and challenges that will prevent local and global jurisdictions reaching elimination targets.
Publication
Slides for a presentation on HCV testing and linkage to treatment among patients attending health services in Victoria, Australia post-DAA introduction
Publication
Slides for a presentation of a trial that aimed to assess the impact of a HCV POC testing on linkage to care and HCV treatment uptake
Publication
A paper published in the Journal of Hepatology that aimed to assess the effectiveness of a nurse-led model of care for the treatment of prisoners with hepatitis C.
Publication
Jacqui Richmond presented at AVHEC 2017 on upskilling the workforce for hepatitis C elimination.
You can see her engaging presentation here: https://vimeo.com/230548507